ADDITIONAL MATERIALS AVAILABLE on the HEI WEBSITE Research Report 198 Understanding the Early Biological Effects of Isoprene-Der

Total Page:16

File Type:pdf, Size:1020Kb

ADDITIONAL MATERIALS AVAILABLE on the HEI WEBSITE Research Report 198 Understanding the Early Biological Effects of Isoprene-Der ADDITIONAL MATERIALS AVAILABLE ON THE HEI WEBSITE Research Report 198 Understanding the Early Biological Effects of Isoprene-Derived Particulate Matter Enhanced by Anthropogenic Pollutants Surratt et al. Appendix A. Quality Assurance and Calibrations for DTT Assay Appendix B. Additional Characterization Results of Exposure Conditions Appendix C. Additional Results from the DTT Assay Appendix D. Cytotoxicity Measurements of Exposure Conditions Appendix E. Genes Analyzed and Additional Gene Expression Data for Exposures These Additional Materials were not formatted or edited by HEI. This document was part of the HEI Review Committee’s review process. Correspondence may be addressed to Dr. Jason D. Surratt, 135 Dauer Drive, 164 Rosenau Hall, Campus Box #7431; e-mail: [email protected]. Although this document was produced with partial funding by the United States Environmental Protection Agency under Assistance Award CR–83467701 to the Health Effects Institute, it has not been subjected to the Agency’s peer and administrative review and therefore may not necessarily reflect the views of the Agency, and no official endorsement by it should be inferred. The contents of this document also have not been reviewed by private party institutions, including those that support the Health Effects Institute; therefore, it may not reflect the views or policies of these parties, and no endorsement by them should be inferred. © 2019 Health Effects Institute, 75 Federal Street, Suite 1400, Boston, MA 02110-1817 Appendix A Quality assurance and calibrations for DTT Assay 0.5 0.4 0.3 0.2 Abs (412 nm) (412 Abs 0.1 0.0 #1 #2 #1: buffer + DTT+ sample #2: buffer + sample + DTT Figure A.1. To test if there are significant differences regarding the order of solution additions under our experimental conditions, we used 1,4-NQ standards to test this order when using the DTT assay. We tested this with the 1,4-NQ standards when adding buffer, then DTT, and then samples versus when adding buffer, then sample, then DTT. No significant difference was observed likely due to agents (solutions) made fresh each time the DTT assay was conducted and also because agents were added within a few minutes in order to prevent DTT from being oxidized in air. (A) (B) Figure A.2. Calibration curves for the measured absorbance versus (A) nmol of DTT consumed and (B) various amount of 1,4-NQ reacted with 25 nmol DTT. 0.65 0.60 0.55 0.50 0.45 0.40 0.35 0.30 0.25 0.20 Abs (412 nm) (412 Abs 0.15 0.10 0.05 0.00 0 10 30 50 Spiking volume of DMSO (µL) Figure A.3. DMSO consuming DTT was negligible up to a spiking volume of 30 µL. However, with a larger spiking volume (i.e., 50 µL), a slightly decreasing absorbance at 412 nm (by 2%) was observed. 0.65 0.60 0.55 0.50 0.45 0.40 0.35 0.30 0.25 0.20 Abs (412 nm) Abs 0.15 0.10 0.05 0.00 Blank filter Blank H2SO4 seed H2SO4 MgSO4 seed MgSO4 H2O+MgSO4 seed H2O+MgSO4 Figure A.4. To examine the effects of aerosol acidity and the presence of Mg2+ on DTT responses, H2SO4 and MgSO4 aerosols were atomized separately into the chamber and collected filter samples (n=3) to compare with the responses from acidified sulfate aerosols (1:1 MgSO4:H2SO4). No significant difference was observed compared to the blank filter samples. APPENDIX B Additional Characterization Results of Exposure Conditions Figure B.1. (a) GC/EI-MS total ion chromatograms (TICs) and (b) UPLC/ESI-HR-QTOFMS base peak chromatograms (BPCs) from a (1) dark control chamber experiment, (2) isoprene- derived SOA exposure chamber experiment, and (3) PM2.5 sample collected from Yorkville, GA during summer 2010. Figure B.2. Time profiles of measured aerosol mass concentrations during the reactive uptake of 166 (A) trans-β-IEPOX, and (B) MAE by acidified sulfate aerosols in chamber experiments. (A) (B) (C) Figure B.3. GC/MS total ion current chromatograms (TICs) of TMS-derivatized particle-phase reaction products from reactive uptake of (A) trans-β-IEPOX and (B) MAE onto acidified sulfate seed aerosol in chamber experiments, and (C) PM2.5 field sample from Yorkville, GA. Mixtures of isomeric SOA products are grouped as one peak. Figure B.4. UPLC/ESI-HR-QTOFMS total ion current chromatograms (TICs) of particle-phase 176 reaction products from reactive uptake of (A) trans-β-IEPOX and (B) MAE onto acidified 177 sulfate seed aerosol in chamber experiments, and (C) a PM2.5 field sample from Yorkville, GA. 178 Figure B.5. Experimental time profile of measured aerosol mass concentrations during ISOPOOH oxidation experiments. Appendix C Additional Results from the DTT Assay Table C.1. DTT activity of PM constituents measured in this study. Results in this study are expressed as mean ± standard error of the mean (SEM), n=3 for each sample. DTT activity Sample (nmol of DTT consumed/min/μg sample) Pure Compounds IEPOX 7.00±1.39 ×10-5 2-MT 4.44±0.92 ×10-5 2-MT_OS 5.77±2.07 ×10-5 MAE 9.84±0.97 ×10-5 2-MG 2.51±0.37 ×10-4 2-MG_OS 7.58±1.14 ×10-5 ISOPOOH 4.90±2.20 ×10-1 Outdoor Chamber Samples Isoprene SOA 2.10±0.22 ×10-3 MACR SOA 2.30±0.27 ×10-3 Indoor Chamber Samples IEPOX-derived SOA 1.79±0.16 ×10-3 MAE-derived SOA 3.13±0.30 ×10-3 Table C.2. Means Comparison (Fisher Test) of Isoprene SOA Types Comparisons of Aerosol Type MeanDiff SEM t Value Prob Alpha Sig LCL UCL MACR SOA vs. isoprene SOA 1.64E-04 2.58E-04 0.6381 0.5413 0.05 0 -4.30E-04 7.59E-04 IEPOX SOA vs. isoprene SOA -4.93E-04 2.58E-04 -1.9133 0.0921 0.05 0 -1.09E-03 1.01E-04 IEPOX SOA vs. MACR SOA -6.58E-04 2.58E-04 -2.5514 0.0341 0.05 1 -1.25E-03 -6.32E-05 MAE SOA vs. isoprene SOA 4.30E-04 2.58E-04 1.6694 0.1336 0.05 0 -1.64E-04 1.02E-03 MAE SOA vs. MACR SOA 2.66E-04 2.58E-04 1.0313 0.3326 0.05 0 -3.29E-04 8.60E-04 MAE SOA vs. IEPOX SOA 9.23E-04 2.58E-04 3.5827 0.0072 0.05 1 3.29E-04 1.52E-03 7.0×10 -1 6.0×10 -1 5.0×10 -1 4.0×10 -1 3.0×10 -1 2.0×10 -1 1.0×10 -1 NIOG 3.0×10 -4 2.0×10 -4 1.0×10 -4 0 MAE 2-MT 2-MG IEPOX 2-MT_OS 2-MG_OS ISOPOOH Figure C.1 NIOG of isoprene-derived epoxides (IEPOX and MAE), their hydrolysis products (2-MT and 2-MG), their organosulfate derivatives (2-MT_OS and 2-MG_OS), and the isoprene- derived hydroxyhydroperoxide (ISOPOOH) that are known to contribute to ambient SOA. APPENDIX D Cytotoxicity Measurements of Exposure Conditions Figure D.1. LDH release for (a) clean air controls, (b) EAVES exposures, normalized to incubator control, and (c) resuspension exposures, normalized to KBM only control. **p<0.005 and ***p<0.0005. Figure D.2. Cytotoxicity for each exposure type for the ISOPOOH-derived SOA system represented as % cell death determined by LDH assay. Appendix E Full Lists of Genes Analyzed and Additional Gene Expression Data of Exposures Table E.1. Gene symbols and full names of 84 oxidative stress-associated genes and housekeeping genes included in RT² Profiler™ PCR Array Human Oxidative Stress Pathway Plus (PAHS-065Y). # Gene Symbol Full Name 1 ALB Albumin 2 ALOX12 Arachidonate 12-lipoxygenase 3 AOX1 Aldehyde oxidase 1 4 APOE Apolipoprotein E 5 ATOX1 ATX1 antioxidant protein 1 homolog (yeast) 6 BNIP3 BCL2/adenovirus E1B 19kDa interacting protein 3 7 CAT Catalase 8 CCL5 Chemokine (C-C motif) ligand 5 9 CCS Copper chaperone for superoxide dismutase 10 CYBB Cytochrome b-245, beta polypeptide 11 CYGB Cytoglobin 12 DHCR24 24-dehydrocholesterol reductase 13 DUOX1 Dual oxidase 1 14 DUOX2 Dual oxidase 2 15 DUSP1 Dual specificity phosphatase 1 16 EPHX2 Epoxide hydrolase 2, cytoplasmic 17 EPX Eosinophil peroxidase 18 FOXM1 Forkhead box M1 19 FTH1 Ferritin, heavy polypeptide 1 20 GCLC Glutamate-cysteine ligase, catalytic subunit 21 GPX1 Glutathione peroxidase 1 22 GPX2 Glutathione peroxidase 2 (gastrointestinal) 23 GPX3 Glutathione peroxidase 3 (plasma) 24 GPX4 Glutathione peroxidase 4 (phospholipid hydroperoxidase) 25 GPX5 Glutathione peroxidase 5 (epididymal androgen-related protein) 26 GSR Glutathione reductase 27 GSS Glutathione synthetase 28 GSTP1 Glutathione S-transferase pi 1 29 GSTZ1 Glutathione transferase zeta 1 30 HSPA1A Heat shock 70kDa protein 1A 31 KRT1 Keratin 1 32 LPO Lactoperoxidase 33 MB Myoglobin 34 MBL2 Mannose-binding lectin (protein C) 2, soluble 35 MPO Myeloperoxidase 36 MPV17 MpV17 mitochondrial inner membrane protein 37 MSRA Methionine sulfoxide reductase A 38 MT3 Metallothionein 3 39 NCF1 Neutrophil cytosolic factor 1 40 NCF2 Neutrophil cytosolic factor 2 41 NOS2 Nitric oxide synthase 2, inducible 42 NOX4 NADPH oxidase 4 43 NOX5 NADPH oxidase, EF-hand calcium binding domain 5 44 NUDT1 Nudix (nucleoside diphosphate linked moiety X)-type motif 1 45 PDLIM1 PDZ and LIM domain 1 46 PRDX1 Peroxiredoxin 1 47 PRDX2 Peroxiredoxin 2 48 PRDX3 Peroxiredoxin 3 49 PRDX4 Peroxiredoxin 4 50 PRDX5 Peroxiredoxin 5 51 PRDX6 Peroxiredoxin 6 52 PRNP Prion protein 53 PTGS1 Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) 54 PTGS2 Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 55 RNF7 Ring finger protein 7 56 VIMP Selenoprotein S 57 SEPP1 Selenoprotein P, plasma, 1 58 SFTPD Surfactant protein D 59 SIRT2 Sirtuin 2 60 SOD1 Superoxide dismutase 1, soluble 61 SOD2 Superoxide dismutase 2, mitochondrial 62 SOD3 Superoxide dismutase 3, extracellular 63 SQSTM1 Sequestosome 1 64 SRXN1 Sulfiredoxin 1 65 TPO Thyroid peroxidase 66 TTN Titin 67 TXNRD2 Thioredoxin reductase 2 68 UCP2 Uncoupling protein 2 (mitochondrial, proton carrier) 69 AKR1C2 Aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) 70 BAG2 BCL2-associated athanogene 2 71 FHL2 Four and a half LIM domains
Recommended publications
  • Lncrna MAFG-AS1 Promotes the Aggressiveness of Breast Carcinoma Through Regulating Mir-339-5P/MMP15
    European Review for Medical and Pharmacological Sciences 2019; 23: 2838-2846 LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15 H. LI1, G.-Y. ZHANG2, C.-H. PAN3, X.-Y. ZHANG1, X.-Y. SU4 1Department of Obstetrics and Gynecology, Shandong Jiyang Public Hospital, Ji’nan, Shandong, China 2Department of Anesthesiology, Shandong Jiyang Public Hospital, Ji’nan, Shandong, China 3Department of Obstetrics and Gynecology, LanCun central hospital, Jimo, Shandong, China 4Department of Critical Care Medicine, Tai’an Central Hospital, Tai’an, Shandong, China Abstract. – OBJECTIVE: The main purposes of and is the leading cause of cancer-related deaths this study are to investigate the possible effects worldwide1. Recently, treatment strategies, such of long noncoding RNAs (lncRNAs) MAFG-AS1 on as chemotherapy, radiotherapy and molecular tar- the growth and metastasis of breast carcinoma. PATIENTS AND METHODS: geting treatment significantly improve the thera- The quantitative 2 Real Time-Polymerase Chain Reaction (qRT- peutic outcome of patients . However, the clinical PCR) assay was used to assess the MAFG-AS1 outcome of patients with breast cancer needs to level in breast cancer tissues and cells. The improve. The metastasis of cancer cells is one ma- wound healing and transwell invasion analy- jor difficulty of overcoming the poor prognosis of sis were applied to explore the invasion and mi- breast cancer patients. The epithelial-mesenchy- gration of breast cancer cell in vitro. The ex- mal transition (EMT) process of cancer cells is a pressions of epithelial-mesenchymal transition 3,4 (EMT) related markers were determined by West- crucial step during metastasis .
    [Show full text]
  • Masre, Siti Fathiah (2015) Analysis of ROCK2 Activation in Transgenic Mouse Skin Carcinogenesis. Phd Thesis
    Masre, Siti Fathiah (2015) Analysis of ROCK2 activation in transgenic mouse skin carcinogenesis. PhD thesis. http://theses.gla.ac.uk/6628/ Copyright and moral rights for this thesis are retained by the author A copy can be downloaded for personal non-commercial research or study This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the Author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the Author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Glasgow Theses Service http://theses.gla.ac.uk/ [email protected] Analysis of ROCK2 Activation in Transgenic Mouse Skin Carcinogenesis Siti Fathiah Masre A Thesis submitted to the University of Glasgow In fulfilment of the requirements for the Degree of Doctor of Philosophy School of Medicine College of Medical, Veterinary and Life Sciences University of Glasgow August 2015 2 Summary The purpose of this study was to investigate ROCK2 activation in squamous cell carcinogenesis and assess its co-operation with rasHa and fos oncogene activation together with loss of PTEN mediated AKT regulation. The analysis of ROCK deregulation with these genes in the MAP Kinase and PI3K pathways, two of the most commonly deregulated signalling systems, employed a well-characterised, transgenic mouse skin model of multi-stage carcinogenesis. A major goal was to study co-operation between these genes in the conversion of benign tumours to malignancy and investigate subsequent progression to aggressive carcinomas, given these are the most significant clinical stages of carcinogenesis from a patient’s viewpoint; and also investigated effects of ROCK2 deregulation on the processes of normal epidermal differentiation.
    [Show full text]
  • C/EBP Creates Elite Cells for Ipsc Reprogramming by Upregulating
    ARTICLES C/EBPα creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4 Bruno Di Stefano1,2,8,9,10, Samuel Collombet3,8, Janus Schou Jakobsen4,5,6,8, Michael Wierer7, Jose Luis Sardina1,2, Andreas Lackner1,2,9, Ralph Stadhouders1,2, Carolina Segura-Morales1,2, Mirko Francesconi1,2, Francesco Limone1,2, Matthias Mann7, Bo Porse4,5,6, Denis Thieffry3 and Thomas Graf1,2,10 Reprogramming somatic cells into induced pluripotent stem cells (iPSCs) is typically inefficient and has been explained by elite-cell and stochastic models. We recently reported that B cells exposed to a pulse of C/EBPα (Bα0 cells) behave as elite cells, in that they can be rapidly and efficiently reprogrammed into iPSCs by the Yamanaka factors OSKM. Here we show that C/EBPα post-transcriptionally increases the abundance of several hundred proteins, including Lsd1, Hdac1, Brd4, Med1 and Cdk9, components of chromatin-modifying complexes present at super-enhancers. Lsd1 was found to be required for B cell gene silencing and Brd4 for the activation of the pluripotency program. C/EBPα also promotes chromatin accessibility in pluripotent cells and upregulates Klf4 by binding to two haematopoietic enhancers. Bα0 cells share many properties with granulocyte/macrophage progenitors, naturally occurring elite cells that are obligate targets for leukaemic transformation, whose formation strictly requires C/EBPα. The ability to reprogram somatic into pluripotent cells has revolu- complex process, where multiple players synergistically establish new tionized stem cell research with major implications for almost all transcriptional networks and remove epigenetic barriers14. Among the fields of modern biology.
    [Show full text]
  • Picosecond-Hetero-FRET Microscopy to Probe Protein-Protein Interactions in Live Cells
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector 3570 Biophysical Journal Volume 83 December 2002 3570–3577 Picosecond-Hetero-FRET Microscopy to Probe Protein-Protein Interactions in Live Cells Marc Tramier,* Isabelle Gautier,* Tristan Piolot,† Sylvie Ravalet,‡ Klaus Kemnitz,† Jacques Coppey,* Christiane Durieux,* Vincent Mignotte,‡ and Maı¨te´ Coppey-Moisan* *Institut Jacques Monod, UMR 7592, CNRS, Universite´s P6/P7, 75251 Paris Cedex 05, France; †EuroPhoton GmbH, D-12247, Berlin, Germany; and ‡ICGM, Department of Hematology, Maternite´ Port-Royal, 75014 Paris, France ABSTRACT By using a novel time- and space-correlated single-photon counting detector, we show that fluorescence resonance energy transfer (FRET) between cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) fused to herpes simplex virus thymidine kinase (TK) monomers can be used to reveal homodimerization of TK in the nucleus and cytoplasm of live cells. However, the quantification of energy transfer was limited by the intrinsic biexponential fluorescence decay of the donor CFP (lifetimes of 1.3 Ϯ 0.2 ns and 3.8 Ϯ 0.4 ns) and by the possibility of homodimer formation between two TK-CFP. In contrast, the heterodimerization of the transcriptional factor NF-E2 in the nucleus of live cells was quantified from the analysis of the fluorescence decays of GFP in terms of 1) FRET efficiency between GFP and DsRed chromophores fused to p45 and MafG, respectively, the two subunits of NF-E2 (which corresponds to an interchromophoric distance of 39 Ϯ 1 Å); and 2) fractions of GFP-p45 bound to DsRed-MafG (constant in the nucleus, varying in the range of 20% to 70% from cell to cell).
    [Show full text]
  • Identification and Characterization of RHOA-Interacting Proteins in Bovine Spermatozoa1
    BIOLOGY OF REPRODUCTION 78, 184–192 (2008) Published online before print 10 October 2007. DOI 10.1095/biolreprod.107.062943 Identification and Characterization of RHOA-Interacting Proteins in Bovine Spermatozoa1 Sarah E. Fiedler, Malini Bajpai, and Daniel W. Carr2 Department of Medicine, Oregon Health & Sciences University and Veterans Affairs Medical Center, Portland, Oregon 97239 ABSTRACT Guanine nucleotide exchange factors (GEFs) catalyze the GDP for GTP exchange [2]. Activation is negatively regulated by In somatic cells, RHOA mediates actin dynamics through a both guanine nucleotide dissociation inhibitors (RHO GDIs) GNA13-mediated signaling cascade involving RHO kinase and GTPase-activating proteins (GAPs) [1, 2]. Endogenous (ROCK), LIM kinase (LIMK), and cofilin. RHOA can be RHO can be inactivated via C3 exoenzyme ADP-ribosylation, negatively regulated by protein kinase A (PRKA), and it and studies have demonstrated RHO involvement in actin-based interacts with members of the A-kinase anchoring (AKAP) cytoskeletal response to extracellular signals, including lyso- family via intermediary proteins. In spermatozoa, actin poly- merization precedes the acrosome reaction, which is necessary phosphatidic acid (LPA) [2–4]. LPA is known to signal through for normal fertility. The present study was undertaken to G-protein-coupled receptors (GPCRs) [4, 5]; specifically, LPA- determine whether the GNA13-mediated RHOA signaling activated GNA13 (formerly Ga13) promotes RHO activation pathway may be involved in acrosome reaction in bovine through GEFs [4, 6]. Activated RHO-GTP then signals RHO caudal sperm, and whether AKAPs may be involved in its kinase (ROCK), resulting in the phosphorylation and activation targeting and regulation. GNA13, RHOA, ROCK2, LIMK2, and of LIM-kinase (LIMK), which in turn phosphorylates and cofilin were all detected by Western blot in bovine caudal inactivates cofilin, an actin depolymerizer, the end result being sperm.
    [Show full text]
  • 4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation
    Methods Mice: 4-6 weeks old female C57BL/6 mice obtained from Jackson labs were used for cell isolation. Female Foxp3-IRES-GFP reporter mice (1), backcrossed to B6/C57 background for 10 generations, were used for the isolation of naïve CD4 and naïve CD8 cells for the RNAseq experiments. The mice were housed in pathogen-free animal facility in the La Jolla Institute for Allergy and Immunology and were used according to protocols approved by the Institutional Animal Care and use Committee. Preparation of cells: Subsets of thymocytes were isolated by cell sorting as previously described (2), after cell surface staining using CD4 (GK1.5), CD8 (53-6.7), CD3ε (145- 2C11), CD24 (M1/69) (all from Biolegend). DP cells: CD4+CD8 int/hi; CD4 SP cells: CD4CD3 hi, CD24 int/lo; CD8 SP cells: CD8 int/hi CD4 CD3 hi, CD24 int/lo (Fig S2). Peripheral subsets were isolated after pooling spleen and lymph nodes. T cells were enriched by negative isolation using Dynabeads (Dynabeads untouched mouse T cells, 11413D, Invitrogen). After surface staining for CD4 (GK1.5), CD8 (53-6.7), CD62L (MEL-14), CD25 (PC61) and CD44 (IM7), naïve CD4+CD62L hiCD25-CD44lo and naïve CD8+CD62L hiCD25-CD44lo were obtained by sorting (BD FACS Aria). Additionally, for the RNAseq experiments, CD4 and CD8 naïve cells were isolated by sorting T cells from the Foxp3- IRES-GFP mice: CD4+CD62LhiCD25–CD44lo GFP(FOXP3)– and CD8+CD62LhiCD25– CD44lo GFP(FOXP3)– (antibodies were from Biolegend). In some cases, naïve CD4 cells were cultured in vitro under Th1 or Th2 polarizing conditions (3, 4).
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Human Small Maf Proteins Form Heterodimers with CNC Family Transcription Factors and Recognize the NF-E2 Motif
    Oncogene (1997) 14, 1901 ± 1910 1997 Stockton Press All rights reserved 0950 ± 9232/97 $12.00 Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif Tsutomu Toki1, Jugou Itoh2, Jun'ichi Kitazawa1, Koji Arai1, Koki Hatakeyama3, Jun-itsu Akasaka4, Kazuhiko Igarashi5, Nobuo Nomura6, Masaru Yokoyama1, Masayuki Yamamoto5 and Etsuro Ito1 1Department of Pediatrics, 2Medicine, School of Medicine; 3Department of Biology, Faculty of Sciences, Hirosaki University, Hirosaki 036; 4Department of Biochemistry, Tohoku University School of Medicine, Sendai 980-77; 5Center for TARA and Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba 305; 6Kazusa DNA Institute, Kisarazu 292, Japan The transcription factor NF-E2, a heterodimeric protein Talbot et al., 1990; Talbot and Grosveld, 1991; complex composed of p45 and small Maf family Kotkow and Orkin, 1995). Recent analyses demon- proteins, is considered crucial for the regulation of strated that NF-E2 is composed of two subunits erythroid gene expression and platelet formation. To (Andrews et al., 1993a,b; Igarashi et al., 1994). The facilitate the characterization of NF-E2 functions in large p45 subunit belongs to a family of basic leucine- human cells, we isolated cDNAs encoding two members zipper (bZip) proteins that is closely related to the of the small Maf family, MafK and MafG. The human Drosophila Cap`n'colar (the CNC family) factor mafK and mafG genes encode proteins of 156 and 162 (Mohler et al., 1991). It cannot bind to the NF-E2 amino acid residues, respectively, whose deduced amino sequence as a homodimer, but does do after forming acid sequences show approximately 95% identity to their heterodimers with chicken small Maf family proteins, respective chicken counterparts.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Molecular Effects of Fermentation in the Gut and Its Relevance for Metabolism and Satiety
    Molecular effects of fermentation in the gut and its relevance for metabolism and satiety Daniëlle Haenen Thesis committee Promotor Prof. Dr Michael R. Müller Professor of Nutrition, Metabolism and Genomics Wageningen University Co-promotors Dr Guido J.E.J. Hooiveld Assistant professor, Division of Human Nutrition Wageningen University Prof. Dr Bas Kemp Professor of Adaptation Physiology Wageningen University Other members Prof. Dr Renger F. Witkamp, Wageningen University Prof. Dr Wouter H. Hendriks, Wageningen University Prof. Dr Michiel Kleerebezem, Wageningen University Prof. Dr Albert K. Groen, University of Groningen This research was conducted under the auspices of the Graduate School VLAG (Advanced studies in Food Technology, Agrobiotechnology, Nutrition and Health Sciences). Molecular effects of fermentation in the gut and its relevance for metabolism and satiety Daniëlle Haenen Thesis submitted in fulfilment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. Dr M.J. Kropff, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Wednesday 18 September 2013 at 1.30 p.m. in the Aula. Daniëlle Haenen Molecular effects of fermentation in the gut and its relevance for metabolism and satiety 210 pages PhD thesis, Wageningen University, Wageningen, NL (2013) With references, with summary in Dutch ISBN 978-94-6173-667-3 Abstract Dietary fibres, the edible parts of plants that are resistant to digestion and absorption in the human small intestine, were shown to be important in the prevention of obesity and the metabolic syndrome. This association can partially be attributed to a fibre-induced increase in satiety.
    [Show full text]
  • Supplementary Material DNA Methylation in Inflammatory Pathways Modifies the Association Between BMI and Adult-Onset Non- Atopic
    Supplementary Material DNA Methylation in Inflammatory Pathways Modifies the Association between BMI and Adult-Onset Non- Atopic Asthma Ayoung Jeong 1,2, Medea Imboden 1,2, Akram Ghantous 3, Alexei Novoloaca 3, Anne-Elie Carsin 4,5,6, Manolis Kogevinas 4,5,6, Christian Schindler 1,2, Gianfranco Lovison 7, Zdenko Herceg 3, Cyrille Cuenin 3, Roel Vermeulen 8, Deborah Jarvis 9, André F. S. Amaral 9, Florian Kronenberg 10, Paolo Vineis 11,12 and Nicole Probst-Hensch 1,2,* 1 Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland; [email protected] (A.J.); [email protected] (M.I.); [email protected] (C.S.) 2 Department of Public Health, University of Basel, 4001 Basel, Switzerland 3 International Agency for Research on Cancer, 69372 Lyon, France; [email protected] (A.G.); [email protected] (A.N.); [email protected] (Z.H.); [email protected] (C.C.) 4 ISGlobal, Barcelona Institute for Global Health, 08003 Barcelona, Spain; [email protected] (A.-E.C.); [email protected] (M.K.) 5 Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain 6 CIBER Epidemiología y Salud Pública (CIBERESP), 08005 Barcelona, Spain 7 Department of Economics, Business and Statistics, University of Palermo, 90128 Palermo, Italy; [email protected] 8 Environmental Epidemiology Division, Utrecht University, Institute for Risk Assessment Sciences, 3584CM Utrecht, Netherlands; [email protected] 9 Population Health and Occupational Disease, National Heart and Lung Institute, Imperial College, SW3 6LR London, UK; [email protected] (D.J.); [email protected] (A.F.S.A.) 10 Division of Genetic Epidemiology, Medical University of Innsbruck, 6020 Innsbruck, Austria; [email protected] 11 MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, W2 1PG London, UK; [email protected] 12 Italian Institute for Genomic Medicine (IIGM), 10126 Turin, Italy * Correspondence: [email protected]; Tel.: +41-61-284-8378 Int.
    [Show full text]
  • Personalized Prediction of Acquired Resistance to EGFR-Targeted Inhibitors Using a Pathway-Based Machine Learning Approach
    Cancers 2019, 11, x S1 of S9 Supplementary Materials: Personalized Prediction of Acquired Resistance to EGFR-Targeted Inhibitors Using a Pathway-Based Machine Learning Approach Young Rae Kim, Yong Wan Kim, Suh Eun Lee, Hye Won Yang and Sung Young Kim Table S1. Characteristics of individual studies. Sample Size Origin of Cancer Drug Dataset Platform S AR (Cell Lines) Lung cancer Agilent-014850 Whole Human GSE34228 26 26 (PC9) Genome Microarray 4x44K Gefitinib Epidermoid carcinoma Affymetrix Human Genome U133 GSE10696 3 3 (A431) Plus 2.0 Head and neck cancer Illumina HumanHT-12 V4.0 GSE62061 12 12 (Cal-27, SSC-25, FaDu, expression beadchip SQ20B) Erlotinib Head and neck cancer Illumina HumanHT-12 V4.0 GSE49135 3 3 (HN5) expression beadchip Lung cancer (HCC827, Illumina HumanHT-12 V3.0 GSE38310 3 6 ER3, T15-2) expression beadchip Lung cancer Illumina HumanHT-12 V3.0 GSE62504 1 2 (HCC827) expression beadchip Afatinib Lung cancer * Illumina HumanHT-12 V4.0 GSE75468 1 3 (HCC827) expression beadchip Head and neck cancer Affymetrix Human Genome U133 Cetuximab GSE21483 3 3 (SCC1) Plus 2.0 Array GEO, gene expression omnibus; GSE, gene expression series; S, sensitive; AR, acquired EGFR-TKI resistant; * Lung Cancer Cells Derived from Tumor Xenograft Model. Table S2. The performances of four penalized regression models. Model ACC precision recall F1 MCC AUROC BRIER Ridge 0.889 0.852 0.958 0.902 0.782 0.964 0.129 Lasso 0.944 0.957 0.938 0.947 0.889 0.991 0.042 Elastic Net 0.978 0.979 0.979 0.979 0.955 0.999 0.023 EPSGO Elastic Net 0.989 1.000 0.979 0.989 0.978 1.000 0.018 AUROC, area under curve of receiver operating characteristic; ACC, accuracy; MCC, Matthews correlation coefficient; EPSGO, Efficient Parameter Selection via Global Optimization algorithm.
    [Show full text]